AIIMS New Delhi Launches Free Cervical Cancer Screening and HPV Services Through January

Updated Jan 8, 2026 | 01:52 PM IST

SummaryAIIMS New Delhi has launched a free cervical cancer screening drive through January to mark Cervical Cancer Awareness Month. The programme offers WHO-recommended HPV testing, follow-up care and vaccination. Women aged 30–65 can undergo screening, while girls aged 9–14 can receive HPV vaccines, aiming to prevent a largely avoidable cancer.
AIIMS New Delhi Launches Free Cervical Cancer Screening and HPV Services Through January

Credits: iStock

AIIMS New Delhi launched free cervical cancer screening through January as a public interest drive. In India, in every 8 minutes, 1 woman loses her life to cervical cancer, however, doctors say that it is highly preventable. Thus, as part of the Cervical Cancer Awareness Month, Preventative Oncology at the Institute of Rotary Cancer Hospital and the National Cancer Institute, in collaboration with the College of Nursing, is offering the WHO-recommended HPV testing, follow-up care, and vaccination.

Also Read: New Food Pyramid 2026 Reshapes Dietary Guidelines For Americans Under RFK Jr

Who Can Undergo These Screening?

  • Women who are of the age 30 to 65 years can undergo cervical and breast cancer screening from Monday to Friday between 9am to 3pm.

  • HPV vaccination is available for girls aged 9 to 14 years on Saturday between 9am to 12 noon at the New RAK Building, AIIMS.

  • Community screening drives are also conducted across NCI Jhajjar through January 2026.

Dr Pallavi Shukla, Associate Professor of Preventative Oncology, AIIMS, who is coordinating the programme said, "This is one cancer which is absolutely preventable. Women should not neglect their health at any age, we must make earnest efforts to eliminate cervical cancer from India."

Also Read: Every Two Minutes, One Woman Loses Her Life To Cervical Cancer: UN

What Is Cervical cancer?

Cervical Cancer is a type of cancer that develops in layers of the cervix. It is caused by abnormal cell growth that can spread to another part of your body. There are two main types of cervical cancer. These are squamous cell carcinoma and adenocarcinoma.

Cervix is located in the pelvic cavity, about 3 to 6 inches inside the vaginal canal. It serves as the entrance to the uterus to the vagina. As per the World Health Organization (WHO), almost all cervial cancer are linked to human papillomaviruses (HPV) which are transmitted through sexual contact.

What Are The Symptoms Of Cervical Cancer?

Cervical cancer has no symptoms in the early days and therefore, is hard to detect until it has spread.

Early-Stage Cervical Cancer Symptoms

  • Vaginal bleeding after sex
  • Vaginal bleeding post-menopause
  • Vaginal bleeding between periods or unusually heavy/long periods
  • Watery vaginal discharge with a strong odour or containing blood
  • Pelvic pain or pain during intercourse
  • Advanced Cervical Cancer Symptoms (when cancer has spread beyond the cervix):

Persistent symptoms of early-stage cervical cancer

  • Painful or difficult bowel movements or rectal bleeding
  • Painful or difficult urination or blood in the urine
  • Persistent dull backache
  • Swelling of the legs
  • Pain in the pelvis or lower abdomen

How Can Cervical Cancer Be Prevented?

Cervical cancer is largely preventable and, when detected early, highly treatable. The World Health Organization recommends HPV vaccination for girls aged 9 to 14, before they become sexually active, along with regular cervical screening from age 30, or 25 for women living with HIV.

Despite this, unequal access to vaccination, screening and treatment continues to drive higher rates of illness and deaths in regions such as sub-Saharan Africa, Central America and Southeast Asia.

End of Article

6 Million People In Delhi Living With Poor Vision: AIIMS Study

Updated Mar 11, 2026 | 11:57 AM IST

SummaryAn estimated one-third of the population in the national capital was identified with refractive errors or presbyopia -- conditions that can usually be corrected with a pair of glasses.
6 Million People In Delhi Living With Poor Vision: AIIMS Study

Credit: Canva

About 6 million people in India's capital city are living with several vision problems, such as poor distance vision or near vision, according to a recent study by doctors at All India Institute of Medical Sciences (AIIMS), New Delhi.

The study, Dr. Rajendra Prasad Centre for Ophthalmic Sciences at AIIMS, and submitted to the World Health Organization (WHO), also flagged major gaps in eye care services in Delhi, the Times of India reported.

An estimated one-third of the population in the national capital was identified with refractive errors or presbyopia -- conditions that can usually be corrected with a pair of glasses. Globally, 826 million people suffer from presbyopia.

About 70 percent of older adults in the capital city were identified with the problem.

Alarmingly, about 13.1 percent school-going children had refractive errors, Dr. Praveen Vashist, professor and head of community ophthalmology at AIIMS, was quoted as saying.

Gaps In Eye Care

The study showed a lack of access to vision correction. While just 60 percent of people needing distance vision correction could access care, those with near vision correction could access care in over 47 percent of cases.

Further, the doctors found:

  • women had the lowest access to spectacles compared to men
  • lack of trained eye care workers,
  • the affordability of spectacles,
  • limited outreach to vulnerable groups -- elderly patients, rural women, and economically weaker populations.
The World Health Organization (WHO) recommends at least one optometrist for every 50,000 people.

But Dr. Vashisth noted that Delhi currently has only 1,085 ophthalmologists and approximately 489 optometrists.

Further, only 50 community-level vision centers, out of the has 249 eye care institutions in the city were found to be functioning. Moreover, only about 25 percent of children were receiving free spectacles through public health initiatives.

Global Eye Burden

According to the World Health Organization (WHO), at least 2.2 billion people worldwide have near or distance vision impairment. Of these, at least 1 billion cases could be prevented with increased access to eyeglasses and cataract surgeries

The WHO identifies refractive errors and cataracts as the leading causes of vision impairment and blindness.

Vision loss can affect people of all ages; however, most people with vision impairment and blindness are over the age of 50.

Here's how to maintain a healthy vision:

  • Eat fruits and veggies, especially leafy greens like spinach, kale, and fish like salmon and tuna, to protect your sight.
  • Be physically active, as being overweight or obese can increase risk for diabetes and other conditions that can lead to vision problems.
  • If your vision gets blurry, use glasses to help you see better.
  • Always wash your hands before putting them close to your eyes, especially if you’re putting in or taking out contact lenses.
  • Use protective eyewear while playing a favorite sport or mowing the lawn
  • Wear your shades to prevent the sun’s rays from hurting your eyes.
  • Give your eyes a break with the 20-20-20 rule: Every 20 minutes, look about 20 feet away for 20 seconds.
  • Quit smoking as it can put you at risk of serious eye issues, leading to blindness.

End of Article

Metal Particle Found In Ibuprofen, Drug Now Recalled

Updated Mar 11, 2026 | 09:38 AM IST

SummaryPharmaceutical company Zentiva recalled a batch of 600mg Ibuflam ibuprofen tablets after a metal fragment was reportedly found. The recall targets wholesalers and pharmacies, with patients allowed to return affected packs for replacement.
Metal Particle Found In Ibuprofen, Drug Now Recalled

Credits: iStock

Ibuflam tablets by pharmaceutical manufacturer Zentiva under the brand name Lichtenstein has been recalled. The 600mg tablets of ibuprofen products were recalled due to contamination. As per several media reports, a piece of metal was found in the tablet which triggered the recall. As per the manufacturer, the affected tablet are the 50-tablet packs with the batch number 5R02514.

Zentiva stated that the recall is explicitly directed at wholesalers and pharmacies, as the company confirmed upon request and the recall is not directed on patients. This measure was taken as a precautionary measure and in consultation with the relevant regulatory authorities.

As of now, patients have the option to return packages from the affected batch and receiving a replacement.

How Can You Return And Receive A New Ibuprofen Prescription?

As per Zentiva, the standard procedure of returning packages from the affected batch and receiving a replacement could be availed. For instance, if the package is almost empty, the standard procedure does not need to be followed, as this could potentially be considered a new prescription. However, patients will have the option of returning packages with the batch number.

A Zentiva spokesperson explained, "The possibility of obtaining a replacement through the supplying pharmacy in case of suspected quality defects always exists. Any connection to the recall lies solely in the fact that the suspicion regarding this batch can generally be considered justified."

This is not a case of re-dispensing under the replacement procedure. It is important to note that when a replacement pack is dispensed in response to a quality complaint, the affected medicinal product is not being placed on the market again, but rather a previously prescribed and supposedly defective medicinal product is being replaced.

Read: THIS Alternative Could Help Prevent Gut Damage Caused By Painkillers

What Is Ibuflam Or Ibuprofen?

Ibuprofen is a nonsteroidal anti-inflammatory drug or NSAID that is used to relieve pain, fever, and inflammation. Ibuflam is a brand name which is a combination medication containing ibuprofen and paracetamol or acetaminophen, which is also designed for enhanced pain relief.

As per the World Health Organization (WHO), ibuprofen is on the list of essential medication. The medicine is used by mouth as a syrup or tablet, and could also be applied directly to the skin as a mousse, gel, or spray.

The uses include:

  • fever
  • inflammation
  • headache
  • menstrual pain
  • common cold
  • toothache
  • back pain
  • arthritis
  • sprains

The medicine could have some side effects, which could include pain, diarrhea or constipation, nausea and vomiting, dyspepsia, bloating, dizziness, headache, nervousness, skin rash, tinnitus, edema or fluid retention.

Who Should Not Use Ibuprofen?

Anyone with:

  • repeated stomach problems like heartburn
  • stomach ulcers
  • bleeding problems
  • high blood pressure
  • heart disease
  • kidney disease
  • age over 60 years

OR

Anyone who:

  • has taken a diuretic
  • is using other NSAIDs or pain relief medication
  • is using anticoagulants
  • is receiving treatment for any serious condition
  • has chickenpox or shingles
  • has Crohn's disease or ulcerative colitis
  • has liver problems

End of Article

Leucovorin Approved By FDA But For A Rare Genetic Disease, Not For Autism

Updated Mar 11, 2026 | 08:51 AM IST

SummaryThe US FDA approved leucovorin only for a rare genetic cerebral folate deficiency affecting about 1 in a million people, rejecting earlier White House suggestions of its broader use for autism treatment.
Leucovorin Approved By FDA But For A Rare Genetic Disease, Not For Autism

Credits: Reuters

The US Food and Drug Administration approved leucovorin, but not for what White House had recommended for in its September briefing. FDA has approved the prescription drug leucovorin for cerebral folate deficiency in the receptor 1 gene, a genetic condition that is estimated to affect only about 1 in 1 million people.

In September, the White House touted leucovorin as a potential treatment for children with autism. Health and Me previously reported on how parents were struggling to find the prescription drug, while not enough scientific evidence was there to support the claim.

What Is Leucovorin?

It is a high-dose B vitamin, which is commonly used as a treatment to counteract the side effects of chemotherapy. It has been approved by the FDA for cerebral folate deficiency in the receptor 1 gene. The disease is rare and fewer than 50 cases have been identified worldwide. FDA Commissioner Dr Marty Makary called this approval "a significant milestone" for patients with the condition.

However, in September last year, Markary and US Health and Human Services Secretary Robert F Kennedy Jr said that the drug could help children with autism. Kennedy, standing next to US President Donald Trump, said, they had "identified an exciting therapy that may benefit large number of children who suffer from autism."

CNN reported that in Austin, Texas, Meagan Johnson, a mother with an autistic son of three years of age, spent four days calling pharmacies across the region searching for leucovorin. She contacted nearly 40 pharmacies around her home in Pflugerville, hoping to locate the medication. Health and Me reported how getting the prescription turned out to be far harder than obtaining it.

This update on leucovorin, notes CNN have hit some families hard, especially the families of children with autism. This is because of the September briefing and when Trump also said that painkiller Tylenol could in fact cause autism. The drug leucovorin was used as something that could give them hope, however, with the update in its label, parents efforts to find the prescription drugs could feel like in vain.

The Rare Condition For Which Drug Got Its Approval

The drug got its approval for folate deficiency in the receptor 1 gene. This is a defect that causes proteins that guide folate into the brain to malfunction. As a result, normal levels of folate is found in the blood, but not in the brain or nervous system, due to which tasks like thinking, speech and movement could not be performed.

Leucovorin Approved By FDA But For A Rare Genetic Disease, Not For Autism

In an op/ed published in Politico and reposted on the White House website last fall, Markary said that his agency would "approve prescription leucovorin as a treatment for children with cerebral folate deficiency and autistic symptoms". However, he did not that it cause not a cure for autism, but there have been studies that show that it could help children with folate deficiency and autism to improve speech by roughly 60 per cent. The Trump administration made a bold move to expand the usage of the drug by "opening the door to the first FDA-recognized treatment for autism." wrote Markary and other HHS leaders.

End of Article